نتایج جستجو برای: upa

تعداد نتایج: 2081  

Journal: :American journal of physiology. Lung cellular and molecular physiology 2000
M R Horton M A Olman C Bao K E White A M Choi B Y Chin P W Noble C J Lowenstein

Pulmonary inflammation and fibrosis are characterized by increased turnover and production of the extracellular matrix as well as an impairment of lung fibrinolytic activity. Although fragments of the extracellular matrix component hyaluronan induce macrophage production of inflammatory mediators, the effect of hyaluronan on the fibrinolytic mediators plasminogen activator inhibitor (PAI)-1 and...

Journal: :International journal of oncology 2007
Christopher S Gondi Neelima Kandhukuri Dzung H Dinh Meena Gujrati Jasti S Rao

Urokinase plasminogen activator (uPA) and its receptor (uPAR) play a major role in invasion and proliferation. A growing body of evidence has suggested that the uPA system promotes tumor metastasis by several different mechanisms, and not just solely by breaking down the ECM. In this study we have used RNAi-mediated simultaneous down-regulation of uPAR and uPA to determine the signaling pathway...

Journal: :Acta biochimica et biophysica Sinica 2005
Chang Tong Li Tan Ping Li Yun-Song Zhu

The urokinase-type plasminogen activator (uPA) plays an important role in cellular invasion. By using the downstream part of a 74 bp DNA region called the cooperation mediator (COM) of the uPA promoter as a bait sequence in the yeast one-hybrid screen, a gene called PBK1 was previously cloned from the cDNA library of the 95D lung cancer cell strain. In this study, the intracellular distribution...

Journal: :BMC Gastroenterology 2006
Kumar Shanmukhappa Gregg E Sabla Jay L Degen Jorge A Bezerra

BACKGROUND The urokinase-type (uPA) and tissue-type (tPA) plasminogen activators regulate liver matrix remodelling through the conversion of plasminogen (Plg) to the active protease plasmin. Based on the efficient activation of plasminogen when uPA is bound to its receptor (uPAR) and on the role of uPA in plasmin-mediated liver repair, we hypothesized that uPA requires uPAR for efficient liver ...

Journal: :American journal of clinical pathology 2007
Alessandro Marco Minisini Dora Fabbro Carla Di Loreto Marta Pestrin Stefania Russo Giovanni Gerardo Cardellino Claudia Andreetta Giuseppe Damante Fabio Puglisi

The urokinase plasminogen activator (uPA) system includes uPA and plasminogen activator inhibitor types 1 (PAI-1) and 2 that mainly act by regulating extracellular matrix degradation, and it is involved in tumor progression. The -675 4G/5G polymorphism of the PAI-1 gene regulates PAI-1 activity in serum. We aimed at studying the -675 4G/5G polymorphism of the PAI-1 gene and uPA, PAI-1, and cycl...

Journal: :Contraception 2006
James Trussell Beth Jordan

Ulipristal Acetate (UPA) One study has demonstrated that UPA can delay ovulation. In this study, 34 women were treated when the size of the leading follicle was at least 18 mm. Each woman contributed one cycle treated with placebo and another with UPA. Follicular rupture failed to occur within 5 days following UPA treatment in 20 (59%) subjects while normal ovulation was observed in all women w...

2017
Jelke Jan Fros Isabelle Dietrich Kinda Alshaikhahmed Tim Casper Passchier David John Evans Peter Simmonds

Most vertebrate and plant RNA and small DNA viruses suppress genomic CpG and UpA dinucleotide frequencies, apparently mimicking host mRNA composition. Artificially increasing CpG/UpA dinucleotides attenuates viruses through an entirely unknown mechanism. Using the echovirus 7 (E7) model in several cell types, we show that the restriction in E7 replication in mutants with increased CpG/UpA dinuc...

Journal: :Journal of the National Cancer Institute 2002
Maxime P Look Wim L J van Putten Michael J Duffy Nadia Harbeck Ib Jarle Christensen Christoph Thomssen Ronald Kates Frédérique Spyratos Mårten Fernö Serenella Eppenberger-Castori C G J Fred Sweep Kurt Ulm Jean-Philippe Peyrat Pierre-Marie Martin Henri Magdelenat Nils Brünner Catherine Duggan Björn W Lisboa Pär-Ola Bendahl Véronique Quillien Alain Daver Gabriel Ricolleau Marion E Meijer-van Gelder Peggy Manders W Edward Fiets Marinus A Blankenstein Philippe Broët Sylvie Romain Günter Daxenbichler Gudrun Windbichler Tanja Cufer Simona Borstnar Willy Kueng Louk V A M Beex Jan G M Klijn Niall O'Higgins Urs Eppenberger Fritz Jänicke Manfred Schmitt John A Foekens

BACKGROUND Urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) play essential roles in tumor invasion and metastasis. High levels of both uPA and PAI-1 are associated with poor prognosis in breast cancer patients. To confirm the prognostic value of uPA and PAI-1 in primary breast cancer, we reanalyzed individual patient data provided by members of the European Organization for ...

Journal: :Blood 1994
T Plesner M Ploug V Ellis E Rønne G Høyer-Hansen M Wittrup T L Pedersen T Tscherning K Danø N E Hansen

The cellular receptor for urokinase-type plasminogen activator (uPAR) binds pro-urokinase (pro-uPA) and facilitates its conversion to enzymatically active urokinase (uPA). uPA in turn activates surface-bound plasminogen to plasmin, a process of presumed importance for a number of biologic processes including cell migration and resolution of thrombi. We have previously shown that uPAR is express...

Journal: :The Journal of Cell Biology 1999
Diem H.D. Nguyen Andrew D. Catling Donna J. Webb Mauricio Sankovic Lori A. Walker Avril V. Somlyo Michael J. Weber Steven L. Gonias

Urokinase-type plasminogen activator (uPA) activates the mitogen activated protein (MAP) kinases, extracellular signal-regulated kinase (ERK) 1 and 2, in diverse cell types. In this study, we demonstrate that uPA stimulates migration of MCF-7 breast cancer cells, HT 1080 fibrosarcoma cells, and uPAR-overexpressing MCF-7 cells by a mechanism that depends on uPA receptor (uPAR)-ligation and ERK a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید